These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 8562256)

  • 1. [The intervention trial in the evaluation of antihypertensive therapy].
    Mancia G; Cattaneo BM; Grassi G
    Ann Ital Med Int; 1995 Oct; 10 Suppl():108S-111S. PubMed ID: 8562256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypertension as a function of age].
    Gensini GF; Corradi F
    Ital Heart J; 2000 Jun; 1 Suppl 2():23-31. PubMed ID: 10905125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk stratification for the prevention of cardiovascular complications of hypertension.
    Girerd X; Giral P
    Curr Med Res Opin; 2004 Jul; 20(7):1137-42. PubMed ID: 15265258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management of severe hypertension in France in 1999 and 2000: intermediate results of a health insurance intervention program].
    Tilly B; Guilhot J; Salanave B; Fender P; Allemand H
    Arch Mal Coeur Vaiss; 2002; 95(7-8):687-94. PubMed ID: 12365081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antihypertensive therapy in the elderly: results of large trials].
    Leonetti G; Cuspidi C; Facchini M
    Ital Heart J Suppl; 2001 Nov; 2(11):1161-9. PubMed ID: 11775407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Arterial hypertension and cardiovascular risk. Epidemiological studies, trials and therapeutic implications].
    Iannetti M; Vallebona A; Caponnetto S
    Minerva Cardioangiol; 1991 Oct; 39(10):367-74. PubMed ID: 1803282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
    Leenen FH
    Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of hypertension: successes and failures of antihypertensive treatment.
    Zanchetti A
    J Hum Hypertens; 1989 Dec; 3 Suppl 2():27-33. PubMed ID: 2691692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension in the elderly.
    Emeriau JP; Decamps A; Manciet G; Dupuy-Braud E; Galley P
    Am J Med; 1988 Jan; 84(1B):92-7. PubMed ID: 3277424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is systolic pressure a better target for antihypertensive treatment than diastolic pressure?
    Leonetti G; Cuspidi C; Facchini M; Stramba-Badiale M
    J Hypertens Suppl; 2000 Jul; 18(3):S13-20. PubMed ID: 10952083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trials in isolated systolic hypertension in the elderly.
    García-Palmieri MR; Torrado JM
    P R Health Sci J; 2003 Jun; 22(2):145-8. PubMed ID: 12866138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypertension: when to consider it a risk factor?].
    Pessina AC; Rossi GP
    Recenti Prog Med; 1992 Sep; 83(9):515-9. PubMed ID: 1439121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Heart, brain and hypertension].
    Lüscher TF; Sturzenegger M; Noll G
    Schweiz Med Wochenschr; 1996 Aug; 126(34):1449-56. PubMed ID: 8848709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased vascular compliance/decreased cardiovascular risk: what the studies tell us.
    Frishman WH
    Heart Dis; 2000; 2(5):384-8. PubMed ID: 11728287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group.
    Dahlöf B; Devereux R; de Faire U; Fyhrquist F; Hedner T; Ibsen H; Julius S; Kjeldsen S; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H
    Am J Hypertens; 1997 Jul; 10(7 Pt 1):705-13. PubMed ID: 9234823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The best of arterial hypertension in 1999].
    Milon H
    Arch Mal Coeur Vaiss; 2000 Jan; 93(1 Spec No):9-15. PubMed ID: 10721443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.